234 related articles for article (PubMed ID: 33785040)
1. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.
Brochado Ó; Martínez I; Berenguer J; Medrano L; González-García J; Jiménez-Sousa MÁ; Carrero A; Hontañón V; Navarro J; Guardiola JM; Fernández-Rodríguez A; Resino S;
J Biomed Sci; 2021 Mar; 28(1):23. PubMed ID: 33785040
[TBL] [Abstract][Full Text] [Related]
2. HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients.
Brochado-Kith Ó; Martínez I; Berenguer J; González-García J; Salgüero S; Sepúlveda-Crespo D; Díez C; Hontañón V; Ibañez-Samaniego L; Pérez-Latorre L; Fernández-Rodríguez A; Ángeles Jiménez-Sousa M; Resino S
Front Immunol; 2021; 12():723196. PubMed ID: 34497613
[TBL] [Abstract][Full Text] [Related]
3. Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients.
Rallon NI; Lopez-Fernandez LA; Garcia MI; Benguria A; Fiorante S; Soriano V; Benito JM
AIDS; 2013 Mar; 27(5):687-96. PubMed ID: 23196939
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of cytotoxicity pathway discriminating between HIV, HCV mono- and co-infection identified by transcriptome profiling of PBMCs.
Wu JQ; Saksena MM; Soriano V; Vispo E; Saksena NK
Virol J; 2015 Jan; 12():4. PubMed ID: 25623235
[TBL] [Abstract][Full Text] [Related]
6. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.
Quaranta MG; Ferrigno L; Tata X; D'Angelo F; Coppola C; Ciancio A; Bruno SR; Loi M; Giorgini A; Margotti M; Cossiga V; Brancaccio G; Dallio M; De Siena M; Cannizzaro M; Cavalletto L; Massari M; Mazzitelli M; De Leo P; Laccabue D; Baiocchi L; Kondili LA
BMC Infect Dis; 2021 May; 21(1):413. PubMed ID: 33947337
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.
Kottilil S; Yan MY; Reitano KN; Zhang X; Lempicki R; Roby G; Daucher M; Yang J; Cortez KJ; Ghany M; Polis MA; Fauci AS
Hepatology; 2009 Jul; 50(1):34-45. PubMed ID: 19551908
[TBL] [Abstract][Full Text] [Related]
8. Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.
Jenabian MA; Mehraj V; Costiniuk CT; Vyboh K; Kema I; Rollet K; Paulino Ramirez R; Klein MB; Routy JP
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):254-62. PubMed ID: 26436613
[TBL] [Abstract][Full Text] [Related]
9. Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.
Nussenblatt V; McLaughlin M; Rehm CA; Lempicki RA; Brann T; Yang J; Proschan M; Highbarger HC; Dewar RL; Imamichi T; Koratich C; Neumann AU; Masur H; Polis MA; Kottilil S
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1354-9. PubMed ID: 18184077
[TBL] [Abstract][Full Text] [Related]
10. Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.
Liu CH; Sun HY; Liu CJ; Sheng WH; Hsieh SM; Lo YC; Liu WC; Su TH; Yang HC; Hong CM; Tseng TC; Chen PJ; Chen DS; Hung CC; Kao JH
Aliment Pharmacol Ther; 2018 Jun; 47(12):1690-1698. PubMed ID: 29665069
[TBL] [Abstract][Full Text] [Related]
11. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Key Elements in the Innate Immunity System Among Patients with HIV, HCV, and Coinfections of HIV/HCV.
Moradi M; Tabibzadeh A; Javanmard D; Ghorbani S; Bokharaei-Salim F; Keivani H; Khazeni M; Monavari SHR
Curr HIV Res; 2020; 18(3):194-200. PubMed ID: 32209045
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
[TBL] [Abstract][Full Text] [Related]
14. HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization.
Valle-Millares D; Brochado-Kith Ó; Gómez-Sanz A; Martín-Carbonero L; Ryan P; De Los Santos I; Castro JM; Troya J; Mayoral-Muñoz M; Cuevas G; Martínez-Román P; Sanz-Sanz J; Muñoz-Muñoz M; Jiménez-Sousa MÁ; Resino S; Briz V; Fernández-Rodríguez A;
Biomed Pharmacother; 2022 Jan; 145():112405. PubMed ID: 34781145
[TBL] [Abstract][Full Text] [Related]
15. Impact of HIV on host-virus interactions during early hepatitis C virus infection.
Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P
J Infect Dis; 2008 Jun; 197(11):1558-66. PubMed ID: 18419344
[TBL] [Abstract][Full Text] [Related]
16. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
Neukam K; Morano-Amado LE; Rivero-Juárez A; Mancebo M; Granados R; Téllez F; Collado A; Ríos MJ; de Los Santos-Gil I; Reus-Bañuls S; Vera-Méndez F; Geijo-Martínez P; Montero-Alonso M; Suárez-Santamaría M; Pineda JA
HIV Clin Trials; 2017 May; 18(3):126-134. PubMed ID: 28599618
[TBL] [Abstract][Full Text] [Related]
17. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Castells L; Rimola A; Manzardo C; Valdivieso A; Montero JL; Barcena R; Abradelo M; Xiol X; Aguilera V; Salcedo M; Rodriguez M; Bernal C; Suarez F; Antela A; Olivares S; Del Campo S; Laguno M; Fernandez JR; de la Rosa G; Agüero F; Perez I; González-García J; Esteban-Mur JI; Miro JM;
J Hepatol; 2015 Jan; 62(1):92-100. PubMed ID: 25127748
[TBL] [Abstract][Full Text] [Related]
18. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Moll A; Jäger H; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
HIV Med; 2018 Apr; 19(4):299-307. PubMed ID: 29368456
[TBL] [Abstract][Full Text] [Related]
19. SEN Virus infection in HIV/HCV coinfected patients.
Sagir A; Adams O; Oette M; Vogel M; Kupfer B; Emmelkamp J; Rockstroh J; Häussinger D
Eur J Med Res; 2008 Nov; 13(11):495-9. PubMed ID: 19073384
[TBL] [Abstract][Full Text] [Related]
20. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
